Changeflow GovPing Trade & Sanctions NIDCD Seeks Input on Clinical Trial Support
Priority review Consultation Added Consultation

NIDCD Seeks Input on Clinical Trial Support

Favicon for grants.nih.gov NIH Guide Funding Opportunities
Published March 17th, 2026
Detected March 18th, 2026
Email

Summary

The National Institute on Deafness and Other Communication Disorders (NIDCD) has issued a Request for Information (RFI) seeking public input on how to strengthen its support for clinical trials. Interested parties are invited to submit comments by April 15, 2026, to help shape the future of NIDCD's clinical trial infrastructure.

What changed

The National Institute on Deafness and Other Communication Disorders (NIDCD) is soliciting feedback through a Request for Information (RFI) to enhance its clinical trial support infrastructure and capabilities. The RFI specifically asks for input on leveraging NIDCD and NIH resources, necessary institutional infrastructure for investigators, challenges in submitting clinical trial applications, difficulties in achieving clinical trial milestones, and capacity building for future clinical scientists. This consultation aims to gather perspectives to guide the NDCD Clinical Trials Workgroup in advancing therapies and interventions for communication disorders.

Regulated entities, particularly those involved in drug and device development for hearing, balance, taste, smell, voice, speech, and language disorders, should review the RFI and consider submitting comments. The deadline for responses is April 15, 2026. While responses are voluntary and can be anonymous, the NIDCD will use the submitted information to inform future program development and potential solicitations. This is an opportunity to influence the direction of clinical research support within NIDCD.

What to do next

  1. Review RFI requirements for input on NIDCD clinical trial support.
  2. Submit comments and recommendations by April 15, 2026.
  3. Consider providing feedback on challenges and opportunities in clinical trial development and execution.

Source document (simplified)

Request for Information (RFI): Seeking Input on the NIDCD Support of Clinical Trials Notice Number: NOT-DC-26-026

Key Dates

Release Date: March 17, 2026 Response Date: April 15, 2026

Related Announcements

None

Issued by

National Institute on Deafness and Other Communication Disorders (NIDCD)

Purpose

The National Institute on Deafness and Other Communication Disorders (NIDCD) is seeking input from interested parties to address strengthening NIDCD clinical trial infrastructure and support.

Background

NIDCD is committed to the development of therapies and interventions to treat and prevent communication and other disorders in our core mission areas: hearing, balance, taste, smell, voice, speech, and language.

The NIDCD actively supports a portfolio of R01 and U01 clinical trials across the seven mission areas of NIDCD focused on advancing interventions across devices, drugs, behavioral strategies, and nutritional approaches. These trials have been strategically managed by a dedicated Clinical Trials Section composed of medical officers, trial experts, statisticians, and operational support staff. The goal of the NIDCD Clinical Trials Section is to ensure appropriate stewardship for NIDCD clinical trials. NIDCD has convened a workgroup of the National Deafness and Other Communication Disorders (NDCD) Advisory Committee to examine how NIDCD can best grow, support and manage clinical trials. A key focus of the NIDCD clinical trials effort is to support the conduct of well-designed, rigorous, high-impact pivotal Phase II studies that lay the foundation for successful Phase III trials, ultimately accelerating the translation of research findings into effective patient care practices and maximizing the impact of federal investment in clinical research.

Information Requested

The NIDCD is seeking input to guide the NDCD Clinical Trials Workgroup on the capabilities and growth of the NIDCD clinical trials program, aimed at advancing therapies and timely interventions for disorders related to hearing, balance, taste, smell, voice, speech, and language. We invite interested parties to share their perspectives on how NIDCD can best support translation of scientific discoveries into effective and accessible treatments and clinical trials that improve the lives of people with communication disorders spanning hearing, balance, taste, smell, voice, speech, and language.

Responses are welcomed on any or all of, but not limited to, the topics below:

  1. Leveraging NIDCD and NIH resources to better support the translation of scientific discoveries into effective clinical trials and patient therapies
  2. Institutional resources and infrastructure needed to enable investigators to successfully plan and implement rigorous high-quality clinical trials in NIDCD mission areas
  3. Challenges to the development and successful submission of a clinical trial application to NIDCD
  4. Clinical trial milestone(s) most difficult to achieve and what could be helpful in addressing this issue
  5. Capacity building training and mentoring to assist the next generation of NIDCD clinical scientists to achieve success How to Submit a Response

All comments must be submitted electronically via email to [email protected]

Responses must be received by 11:59:59 pm (ET) on April 15, 2026

Responses to this RFI are voluntary and may be submitted anonymously. Please do not include any personally identifiable information or any information that you do not wish to make public. Proprietary, classified, confidential, or sensitive information should not be included in your response. NIH will use the information submitted in response to this RFI at its discretion. NIH reserves the right to use any submitted information on public websites, in reports, in summaries of the state of the science, in any possible resultant solicitation(s), grant(s), or cooperative agreement(s), or in the development of future funding opportunity announcements. This RFI is for informational and planning purposes only and is not a solicitation for applications or an obligation on the part of the Government to provide support for any ideas identified in response to it. Please note that the Government will not pay for the preparation of any information submitted or for use of that information.

We look forward to your input and hope that you will share this RFI opportunity with your colleagues.

Inquiries

Please direct all inquiries to:

National Institute on Deafness and Other Communication Disorders (NIDCD)

Email: [email protected]

Weekly TOC for this Announcement
NIH Funding Opportunities and Notices Department of Health
and Human Services (HHS) NIH... Turning Discovery Into Health ®

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
NIH
Published
March 17th, 2026
Compliance deadline
April 15th, 2026 (28 days)
Instrument
Consultation
Legal weight
Non-binding
Stage
Consultation
Change scope
Substantive

Who this affects

Applies to
Drug manufacturers Pharmaceutical companies Healthcare providers
Geographic scope
National (US)

Taxonomy

Primary area
Healthcare
Operational domain
Research and Development
Topics
Clinical Trials Research Funding Public Health

Get Trade & Sanctions alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when NIH Guide Funding Opportunities publishes new changes.

Free. Unsubscribe anytime.